Select Medical Holdings Corporation (SEM) financial statements (2022 and earlier)

Company profile

Business Address C/O SELECT MEDICAL CORP
MECHANICSBURG, PA 17055
State of Incorp.
Fiscal Year End December 31
SIC 806 - Hospitals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments74748803750577640510
Cash and cash equivalents74748803750577640510
Receivables889899931960897843749
Prepaid expense5615566249
Other current assets12011712812011411895
Total current assets:1,1391,7791,8681,8351,5941,6241,363
Noncurrent Assets
Operating lease, right-of-use asset1,0791,0701,0531,0541,0321,0061,023
Property, plant and equipment961937928931943928959
Intangible assets, net (including goodwill)3,8243,7783,7713,7753,7673,7623,789
Goodwill3,4493,4003,3913,3903,3793,3693,391
Intangible assets, net (excluding goodwill)375378380384388393398
Other noncurrent assets357335335326319341334
Total noncurrent assets:6,2216,1206,0886,0856,0616,0366,105
TOTAL ASSETS:7,3607,8997,9567,9217,6557,6607,468
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities653624670646576552538
Accounts payable234192188189177160143
Accrued liabilities244250256253229239204
Employee-related liabilities144140147141133125125
Taxes payable131515381737
Interest and dividends payable29102910291030
Debt1818121513216217
Due to related parties22   31  
Other undisclosed current liabilities581684727879819578501
Total current liabilities:1,2731,3261,4091,5401,4381,3451,256
Noncurrent Liabilities
Long-term debt and lease obligation, including:3,5563,3843,3863,3873,389866866
Finance lease, liability171414141314 
Operating lease, liability917910893895875853866
Other undisclosed long-term debt and lease obligation2,6232,4612,4792,4792,501  
Liabilities, other than long-term debt249288296302301310288
Deferred income tax liabilities143120124133132131145
Other liabilities106168173169169179143
Other undisclosed noncurrent liabilities9179108938958753,3773,390
Total noncurrent liabilities:4,7224,5824,5764,5844,5664,5544,544
Total liabilities:5,9955,9095,9856,1246,0045,8995,800
Temporary equity, carrying amount39627522446398542496
Stockholders' equity
Stockholders' equity attributable to parent1,1101,1451,2341,1461,0601,039993
Common stock0000000
Additional paid in capital504502516514509501497
Accumulated other comprehensive income (loss)12456(2)  
Retained earnings593639713625553537496
Stockholders' equity attributable to noncontrolling interest216218216205192180180
Total stockholders' equity:1,3261,3641,4501,3511,2531,2191,172
TOTAL LIABILITIES AND EQUITY:7,3607,8997,9567,9217,6557,6607,468

Income statement (P&L) ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues1,5601,5341,5641,5461,4601,4241,233
Cost of revenue(1,405)(1,298)(1,291)(1,298)(1,269)(1,181)(1,082)
Cost of goods and services sold(1,403)(1,298)(1,291)(1,293) (1,181)(1,082)
Gross profit:154237273248192243150
Operating expenses(87)(88)(87)(80)(65)(86)(86)
Other operating income (expense), net102983436(1)55
Operating income:78150284202163156120
Nonoperating income (expense)
(Investment Income, Nonoperating)
    (0)50
Interest and debt expense(34)(34)(34)(34)(36)(34)(37)
Other undisclosed income from continuing operations before equity method investments, income taxes2      
Income from continuing operations before equity method investments, income taxes:4611625016812812782
Income from equity method investments111112101098
Other undisclosed income from continuing operations before income taxes1  5   
Income from continuing operations before income taxes:5812826218213713691
Income tax expense (benefit)9(28)(66)(45)(35)(32)(23)
Net income:6610019613710210467
Net loss attributable to noncontrolling interest(16)(23)(31)(27)(25)(28)(16)
Net income attributable to parent:5077165111777752
Undistributed earnings (loss) allocated to participating securities, basic (3)(6)(4)(3)(3)(2)
Other undisclosed net loss available to common stockholders, basic(2)      
Net income available to common stockholders, diluted:4874159107757450

Comprehensive Income ($ in millions)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net income:6610019613710210467
Other comprehensive income (loss)3(1)(1)(3)   
Other undisclosed comprehensive income (loss)5  11(2)  
Comprehensive income:7410019514510010467
Comprehensive loss, net of tax, attributable to noncontrolling interest(16)(23)(31)(27)(25)(28)(16)
Comprehensive income, net of tax, attributable to parent:5876163119757752

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: